In silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2

Jyoti Rani, Anasuya Bhargav, Faez Iqbal Khan, Srinivasan Ramachandran, Dakun Lai, Urmi Bajpai*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a colossal loss to human health and lives and has deeply impacted socio-economic growth. Remarkable efforts have been made by the scientific community in containing the virus by successful development of vaccines and diagnostic kits. Initiatives towards drug repurposing and discovery have also been undertaken. In this study, we compiled the known natural anti-viral compounds using text mining of the literature and examined them against four major structural proteins of SARS-CoV-2, namely, spike (S) protein, nucleocapsid (N) protein, membrane (M) protein and envelope (E) protein. Following computational approaches, we identified fangchinoline and versicolactone C as the compounds to exhibit strong binding to the target proteins and causing structural deformation of three structural proteins (N, S and M). We recommend the inhibitory effects of these compounds from our study should be experimentally validated against SARS-CoV-2. Communicated by Ramaswamy H. Sarma.

Original languageEnglish
Pages (from-to)12118-12134
Number of pages17
JournalJournal of Biomolecular Structure and Dynamics
Volume40
Issue number22
DOIs
Publication statusPublished - 2022
Externally publishedYes

Keywords

  • COVID-19
  • SARS-CoV-2
  • docking
  • natural antiviral compounds
  • simulation

Fingerprint

Dive into the research topics of 'In silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2'. Together they form a unique fingerprint.

Cite this